Media Coverage header image

Media Coverage

Advanced Search
  • 03132025
    Modern Healthcare

    What did you learn from running a business during the pandemic that you apply to your operations today? James Davis, chair and CEO, Quest Diagnostics: Quest played a critical role supporting the nation’s response to the COVID-19 pandemic with our high-quality molecular diagnostic and serology antibody testing. While the team scaled COVID-19 testing capacity in record time, the experience revealed the value of partnerships with public health and other groups to anticipate and prepare for threats in advance. We recently put this lesson to work through a new Centers for Disease Control and Prevention preparedness arrangement, which enabled us to launch the nation’s first commercial H5 avian flu test late last year.

  • 02252025
    Modern Healthcare

    Quest Diagnostics plans to buy select assets of Fresenius Medical Care’s laboratory testing services business Spectra Laboratories for an undisclosed amount. The sale fits in with Fresenius' goal of divesting non-core, lower-margin assets, CEO Helen Giza said Tuesday during the company’s fourth-quarter earnings call. The deal is expected to close in the second half of the year, the company said in a news release.

  • 02062025
    WebMD

    Forever chemicals, PFAS (per- and poly-fluoroalkyl substances), endocrine disruptors, microplastics: These modern-day pollutants and man-made chemicals designed for durability are seemingly everywhere. They’re in food, water, everyday products (think: plastic or clothes), indoor and outdoor air, and – as their adverse health effects become more and more evident – they’re all over the news. Still stressed? Ask your health care provider for a “body burden” test (usually a blood test); Quest Diagnostics has a PFAS test panel.

  • 01272025
    Becker's Hospital Review

    Cleveland-based University Hospitals has completed the sale of select assets of its outreach laboratory services business to Quest Diagnostics. Under the agreement, Quest's labs in Twinsburg, Ohio, and Pittsburgh will handle testing for UH providers and patients who use Quest's lab services, according to a Jan. 27 news release. UH will continue to offer inpatient and select outpatient testing through its hospital-based labs. UH and Quest announced a definitive agreement in August.

  • 01082025
    360Dx

    Quest Diagnostics named Adrienne Brott its SVP and chief quality and regulatory affairs officer. She will oversee the firm's quality and regulatory strategy, as well as its efforts complying with US and global regulations and industry standards.

  • 12232024
    Medical Laboratory Observer

    Meghan W. Starolis, MS, PhD, HCLD(ABB), Senior Science Director of Infectious Disease at Quest Diagnostics, explains how can laboratory professionals can ensure they are staying on top of testing, diagnosis, and treatment for respiratory illnesses that are growing in prevalence even before the traditional ‘cold and flu’ season.

  • 12192024
    Lab Pulse

    Mainz Biomed has announced that it has made an agreement with Quest Diagnostics in which Quest will support the commercialization of Mainz Biomed's next-generation ColoAlert colorectal cancer (CRC) screening test. Under the terms of the agreement, Quest will provide clinical trial laboratory services for Mainz Biomeds’ ReconAAsense study, a prospective clinical study that includes approximately 15,000 subjects from 150 sites across the U.S. intended to provide data in support of the test’s submission for U.S. Food and Drug Administration (FDA) approval, Mainz said in a statement.

  • 12092024

    If you’ve had any medical tests over the past few decades, chances are you have encountered Quest Diagnostics. The Secaucus-based laboratory testing company boasts that it serves one-third of all Americans and works with half of the physicians and hospitals around the country.

  • 11152024
    360Dx

    Autoimmune diagnostics company Augurex Life Sciences said Friday that it has entered a nonexclusive agreement with Quest Diagnostics under which Quest will validate and offer in the United States a laboratory-developed test based on Augurex's 14-3-3eta biomarker.

  • 11072024
    Fierce Healthcare

    Quest Diagnostics and Elevance Health are broadening their partnership into four more states with the goal of making it easier for patients to access in-network laboratory services. Beginning Jan. 1, Quest's service will be available in-network in four additional states: Colorado, Georgia, Nevada and Virginia. This includes routine lab testing, advanced diagnostics and Quest's network of pathologists, according to an announcement.

Show 5102550100 per page